[Flu and antiviral agents....].
Vallée
J P
JP
D000081:Acetamides / Q000008:administration & dosage / Q000627:therapeutic use*; D000281:Administration, Intranasal; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004311:Double-Blind Method; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006146:Guanidines; D006801:Humans; D007252:Influenza Vaccines / Q000008:administration & dosage; D007251:Influenza, Human / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged; D009439:Neuraminidase / Q000008:administration & dosage / Q000037:antagonists & inhibitors*; D053139:Oseltamivir; D010919:Placebos; D011714:Pyrans; D012307:Risk Factors; D012794:Sialic Acids / Q000008:administration & dosage / Q000627:therapeutic use; D053243:Zanamivir
D000081:Acetamides; D000998:Antiviral Agents; D004791:Enzyme Inhibitors; D006146:Guanidines; D007252:Influenza Vaccines; D010919:Placebos; D011714:Pyrans; D012794:Sialic Acids; D053139:Oseltamivir; D009439:Neuraminidase; D053243:Zanamivir